These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 16054696)
1. Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persist. Voleti B; Agrawal A Mol Immunol; 2006 Mar; 43(7):891-6. PubMed ID: 16054696 [TBL] [Abstract][Full Text] [Related]
2. Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins. Arnaud C; Burger F; Steffens S; Veillard NR; Nguyen TH; Trono D; Mach F Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1231-6. PubMed ID: 15790934 [TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin reduces interleukin-6-induced expression of C-reactive protein in human hepatocytes in a STAT3- and C/EBP-dependent fashion. Mayer C; Gruber HJ; Landl EM; Pailer S; Scharnagl H; Truschnig-Wilders M; März W Int J Clin Pharmacol Ther; 2007 Jun; 45(6):319-27. PubMed ID: 17595889 [TBL] [Abstract][Full Text] [Related]
4. Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro. Kleemann R; Verschuren L; de Rooij BJ; Lindeman J; de Maat MM; Szalai AJ; Princen HM; Kooistra T Blood; 2004 Jun; 103(11):4188-94. PubMed ID: 14976045 [TBL] [Abstract][Full Text] [Related]
5. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia. Joukhadar C; Klein N; Prinz M; Schrolnberger C; Vukovich T; Wolzt M; Schmetterer L; Dorner GT Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586 [TBL] [Abstract][Full Text] [Related]
6. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin. Hu WL; Qiao SB; Li JJ Cytokine; 2007 Dec; 40(3):201-6. PubMed ID: 18023360 [TBL] [Abstract][Full Text] [Related]
7. C-reactive protein levels and outcomes after statin therapy. Ridker PM; Cannon CP; Morrow D; Rifai N; Rose LM; McCabe CH; Pfeffer MA; Braunwald E; N Engl J Med; 2005 Jan; 352(1):20-8. PubMed ID: 15635109 [TBL] [Abstract][Full Text] [Related]
8. Protein kinase C pathway is involved in transcriptional regulation of C-reactive protein synthesis in human hepatocytes. Ivashchenko Y; Kramer F; Schäfer S; Bucher A; Veit K; Hombach V; Busch A; Ritzeler O; Dedio J; Torzewski J Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):186-92. PubMed ID: 15539624 [TBL] [Abstract][Full Text] [Related]
9. Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors. Kubota T; Fujisaki K; Itoh Y; Yano T; Sendo T; Oishi R Biochem Pharmacol; 2004 Jun; 67(12):2175-86. PubMed ID: 15163549 [TBL] [Abstract][Full Text] [Related]
10. Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis. Tikiz C; Utuk O; Pirildar T; Bayturan O; Bayindir P; Taneli F; Tikiz H; Tuzun C J Rheumatol; 2005 Nov; 32(11):2095-101. PubMed ID: 16265685 [TBL] [Abstract][Full Text] [Related]
11. Role of STAT3 and C/EBP in cytokine-dependent expression of the mouse serum amyloid P-component (SAP) and C-reactive protein (CRP) genes. Ochrietor JD; Harrison KA; Zahedi K; Mortensen RF Cytokine; 2000 Jul; 12(7):888-99. PubMed ID: 10880233 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1beta stimulates acute phase response and C-reactive protein synthesis by inducing an NFkappaB- and C/EBPbeta-dependent autocrine interleukin-6 loop. Kramer F; Torzewski J; Kamenz J; Veit K; Hombach V; Dedio J; Ivashchenko Y Mol Immunol; 2008 May; 45(9):2678-89. PubMed ID: 18262272 [TBL] [Abstract][Full Text] [Related]
13. hsCRP and HDL effects of statins trial (CHEST): rapid effect of statin therapy on C-reactive protein and high-density lipoprotein levels A clinical investigation. Ansell BJ; Watson KE; Weiss RE; Fonarow GC Heart Dis; 2003; 5(1):2-7. PubMed ID: 12549983 [TBL] [Abstract][Full Text] [Related]
14. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway. Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254 [TBL] [Abstract][Full Text] [Related]
15. Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide. Li JJ; Chen XJ Coron Artery Dis; 2003 Jun; 14(4):329-34. PubMed ID: 12826933 [TBL] [Abstract][Full Text] [Related]
16. Ursolic acid suppresses IL-6 induced C-reactive protein expression in HepG2 and protects HUVECs from injury induced by CRP. Lv YY; Jin Y; Han GZ; Liu YX; Wu T; Liu P; Zhou Q; Liu KX; Sun HJ Eur J Pharm Sci; 2012 Jan; 45(1-2):190-4. PubMed ID: 22108347 [TBL] [Abstract][Full Text] [Related]
17. Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients. Chang JW; Yang WS; Min WK; Lee SK; Park JS; Kim SB Am J Kidney Dis; 2002 Jun; 39(6):1213-7. PubMed ID: 12046033 [TBL] [Abstract][Full Text] [Related]
18. The effect of interleukin-1 on C-reactive protein expression in Hep3B cells is exerted at the transcriptional level. Zhang D; Jiang SL; Rzewnicki D; Samols D; Kushner I Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):143-8. PubMed ID: 7646436 [TBL] [Abstract][Full Text] [Related]
19. Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitors. Calza L; Trapani F; Bartoletti M; Manfredi R; Colangeli V; Borderi M; Grossi G; Motta R; Viale P HIV Clin Trials; 2012; 13(3):153-61. PubMed ID: 22592095 [TBL] [Abstract][Full Text] [Related]